Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Moiseyenko VM, Tjulandin SA, et al. V325 Study Group Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 study group. J Clin Oncol 2006;24:4991-7
   PubMed Web of Science ®Google Scholar
• Roth AD, Fazio N, Stupp R, et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 2006;25:3217-23
   Web of Science ®Google Scholar
• Kim KH, Kwon HC, Oh SY, et al. Clinicopathological significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy. Biomarkers 2011;16:74-82
   PubMed Web of Science ®Google Scholar
• Lim JB, Kim DK, Chung HW. Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker. Cancer Sci 2014;105:1327-33
   PubMed Web of Science ®Google Scholar
• Cho IR, Park JC, Park CH, et al. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer 2014;17:703-10
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54
   PubMed Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, et al. The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes inpatients with unresectable metastatic colorectal cancer. BMC Cancer 2015;15:347
   PubMed Web of Science ®Google Scholar
• Park S, Park S, Lee SH, et al. Pretreatment albumin to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer. Cancer Biomarkers 2016;16:425-33
   PubMed Web of Science ®Google Scholar
• Zhang F, Sun P, Wanget ZQ, et al. Low pre operative albumin globulin score predicts favorable survival in esophageal squamous cell carcinoma. Oncotarget 2016;21:30550-60
   Google Scholar
• Azab BN, Bhatt VR, Vonfrolio V, et al. Value of the pretreatment albumin to globulin ratio in predicting longterm mortality in breast cancer patients. Am J Surg 2013;206:764-70
   PubMed Web of Science ®Google Scholar
• Mao MJ, Wei XL, Sheng H, et al. Clinical significance of preoperative albumin and globulin ratio in patients with gastric cancer undergoing treatment. BioMed Res Int 2017;2017:3083267
   PubMed Web of Science ®Google Scholar
• Liu J, Chen Q, Liu X, et al. Prognostic value of pretreatment albumin-globulin ration in predicting long-term mortality in gastric cancer patients who underwent D2 resection. Onco Targets Ther 2017;10:2155-62
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Yasuda H, Ohi M, et al. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. Am J Surg 2017;213:120-6
   PubMed Web of Science ®Google Scholar
• Xue F, Lin F, Yin M, et al. Preoperative albumin/globulin ratio is a potential prognosis predicting biomarker in patients with resectable gastric cancer. Turk J Gastroenterol 2017;28:439-45
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Furukawa Y, Li M, et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 2002;62:7012-17
   PubMed Web of Science ®Google Scholar
• Kim JP, Lee JH, Kim SJ, et al. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998;1:125-33
   PubMedGoogle Scholar
• Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg 1998;228:449-61
   PubMed Web of Science ®Google Scholar
• Laursen I, Briand P, Lykkesfeldt AE. Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 1990;10:343-51
   PubMed Web of Science ®Google Scholar
• McMillan DC, Watson WS, O’Gorman P, et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 2001;39:210-13
   PubMed Web of Science ®Google Scholar
• Yamashita K, Ushiku H, Katada N, et al. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. Eur J Surg Oncol 2015;41:1324-32
   PubMed Web of Science ®Google Scholar
• Fujii T, Sutoh T, Moritaetal H. Serum albumin is superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer. Nutr Cancer 2012;64:1169-73
   PubMed Web of Science ®Google Scholar
• Arrieta O, MichelOrtega RM, Villanueva-Rodríguez G, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatinchemotherapy: a prospective study. BMC Cancer 2010;10:50
   PubMed Web of Science ®Google Scholar
• Liu X, Meng QH, Ye Y, et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non metastatic breast cancer. Carcinogenesis 2015;36:243-8
   PubMed Web of Science ®Google Scholar
• Bizzo SM, Meira DD, Lima JM, et al. Serum albumin and vascular endothelial growth factor in epithelial ovarian cancer: looking at adnexal tumor drainage. Arch Gynecol Obstet 2011;283:855-9
   PubMed Web of Science ®Google Scholar
• Chang WJ, Du Y, Zhao X, et al. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014;20:4586-96
   PubMed Web of Science ®Google Scholar
• Du XJ, Tang LL, Mao YP, et al. The pretreatment albumin to globulin ratio has predictive value for long term mortality in nasopharyngeal carcinoma. PLoS One 2014;9:e94473
   PubMed Web of Science ®Google Scholar
• Adly L, Hill D, Shermanetal ME. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in post menopausal women. Int J Cancer 2006;119:2402-7
   PubMed Web of Science ®Google Scholar
• Park JH, Watt DG, Roxburgh CS, et al. Colorectal cancer, systemic inflammation, and outcome: Staging the tumor and staging the host. Ann Surg 2016;263:326-36
   PubMed Web of Science ®Google Scholar
• Guo YZ, Pan L, Du CJ, et al. Association between creactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pacific J Cancer Prev 2013;14:243-8
   PubMed Web of Science ®Google Scholar